正在加载视频...

视频加载失败

Representing a state before the world's leading companies requires vision, confidence, credibility, and unwavering commitment. During his tenure, KTR played a key role in positioning Telangana as a leading destination for IT investments, innovation, and global partnerships. His emphasis on fostering innovation, attracting world-class investments, and building international collaborations...

29,417 次观看 • 1 个月前 •via X (Twitter)

1 条评论

𝓝OG .🏇🏻 的头像
𝓝OG .🏇🏻1 个月前

@KTRBRS Quality life 😄🤣

相关视频

Hon’ble Chief Minister Shri Revanth Reddy reiterated that the State Government is committed to extending all necessary support to companies seeking to invest in #Hyderabad. He noted that several leading life sciences companies have already established Global Capability Centres (GCCs) in the city, further strengthening its position as a premier investment destination. * On the sidelines of #BioAsia2026 on Tuesday, the Chief Minister, along with Industries Minister Shri Sridhar Babu Duddilla, met with top executives and representatives of leading global life sciences companies to discuss investment opportunities and expansion plans. * Building on this momentum, the Chief Minister proposed the development of a dedicated GCC zone within #BharatFutureCity, with a special emphasis on establishing innovation centres for global life sciences companies. Details of Investments Announced: * Opella Healthcare - The global consumer healthcare company, spun off from Sanofi and headquartered in France, is expanding its GCC operations in Hyderabad with a 42,000 sq. ft. facility. The expansion is expected to generate up to 500 jobs over the next year. * Vaksindo Animal Health Pvt. Ltd - A division of JAPFA, the company is establishing a state-of-the-art BSL-3 vaccine manufacturing facility in Genome Valley. The facility will focus on producing vaccines for poultry, cattle, swine, and aquaculture. * Tredence Inc. - The AI and data science company is launching its Hyderabad operations as a dedicated innovation hub focused on AI-driven healthcare and life sciences analytics. The facility will span approximately 18,000 sq. ft. and support its global operations. * Rx Propellant (RxP) – The company will develop a new large-format life sciences campus in #GenomeValley, Hyderabad, as part of its long-term commitment to strengthening India’s life sciences ecosystem. The project will comprise over 1 million square feet of advanced laboratory infrastructure spread across nearly 12 acres and will be delivered in phases over the next six years. * With these initiatives, #Telangana further strengthens its position as a leading global hub for life sciences and innovation. #TelanganaLifeSciences #BioAsia #Pharma #TelanganaRising2047

Telangana CMO

15,282 次观看 • 7 个月前

We’re delighted to announce that the CEPI Board has appointed Professor Ibrahim Abubakar (Ibrahim Abubakar) as CEPI’s next Chief Executive Officer. Professor Abubakar, currently Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London (UCL), will take up the role in April 2027. Richard Hatchett, who has led CEPI since its founding in 2017, will remain as CEO until the end of his full term in April 2027, ensuring a smooth transition. Welcoming Professor Abubakar to CEPI, Hon Prof Jane Halton, Chair of the CEPI Board, said: “Ibrahim’s appointment reflects an outstanding track record of delivery and achievement from leading the Lancet Nigeria Commission to acting as an advisor to the Nigerian Presidential Taskforce through to his current role at UCL. He has a clear, personal commitment to the values that make CEPI unique: international collaboration and scientific excellence in service of equitable access for everyone, everywhere. The world cannot afford to be caught unprepared by the next pandemic, and under Ibrahim’s leadership I am confident CEPI will be ready.” Professor Abubakar brings extensive leadership experience across global public health and international organisations. He most recently served as Vice-Provost and Professor of Infectious Disease Epidemiology at UCL, overseeing the University’s health strategy and a portfolio of research, innovation and clinical partnerships. “Through its focus on innovation and equitable access, CEPI has made huge progress over the last decade”, said Professor Abubakar. “I believe there is an opportunity to build on that progress and make a transformational difference to how the world tackles epidemics and pandemics. I am truly honoured to be given the opportunity to take on this role and am looking forward to leading CEPI through its next chapter.” Please join us in welcoming Professor Ibrahim Abubakar to CEPInding track record of delivery and achievement from leading the Lancet Nigeria Commission to acting as an advisor to the Nigerian Presidential Taskforce through to his current role at UCL. He has a clear, personal commitment to the values that make CEPI unique: international collaboration and scientific excellence in service of equitable access for everyone, everywhere. The world cannot afford to be caught unprepared by the next pandemic, and under Ibrahim’s leadership I am confident CEPI will be ready.” Professor Abubakar brings extensive leadership experience across global public health and international organisations. He most recently served as Vice-Provost and Professor of Infectious Disease Epidemiology at UCL, overseeing the University’s health strategy and a portfolio of research, innovation and clinical partnerships. “Through its focus on innovation and equitable access, CEPI has made huge progress over the last decade”, said Professor Abubakar. “I believe there is an opportunity to build on that progress and make a transformational difference to how the world tackles epidemics and pandemics. I am truly honoured to be given the opportunity to take on this role and am looking forward to leading CEPI through its next chapter.” Please join us in welcoming Professor Ibrahim Abubakar to CEPI!

CEPI

51,176 次观看 • 1 个月前